Cullinan Therapeutics, Inc. revenue

Cullinan Therapeutics, Inc.'s revenue was $0 in fiscal 2022, down 100.0% on the year before.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cullinan Therapeutics, Inc.: revenue history, annual
Fiscal year	2020Dec 2020	2021Dec 2021	2022Dec 2022
Revenue	0	19	0
Growth on the year before	—	—	−100.0%

US$ millions unless shown otherwise. Fiscal quarters.

Cullinan Therapeutics, Inc.: revenue history, quarterly
Quarter	2021 Q1Mar 2021	2021 Q2Jun 2021	2021 Q3Sept 2021	2021 Q4Dec 2021	2022 Q1Mar 2022	2022 Q2Jun 2022	2022 Q3Sept 2022	2022 Q4Dec 2022
Revenue	19	0	0	0	0	0	0	0
Growth on the same quarter a year before	—	—	—	—	−100.0%	—	—	—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Cullinan Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cullinan Therapeutics, Inc.